Pascale V Guillot PhD
Head, Cellular Reprogramming and Perinatal Therapy Group. Institute for Women’s Health, Maternal and Fetal Medicine, University College London, 30 Guilford Street, London WC1N 1EH, UK.
Our work focuses on understanding the biology and therapeutic potential of mesenchymal stem cells derived from induced pluripotent stem cells, particularly amniocytes, in models of inflammatory pathologies. We also study the use of fetal stem cells as a countermeasure to bone fragility in osteogenesis imperfecta.
w: http://www.instituteforwomenshealth.ucl.ac.uk/maternal-fetal-medicine/crptg
t: +44 (0) 7703 343449
The Bloomsbury Centre for Skeletal Research 